Antineuroblastoma antibody NB-84 also identifies a significant subset of other small blue round cell tumors

Applied Immunohistochemistry and Molecular Morphology

Volumn 5, Issue 4, 1997, Pages 239-245

  Folpe, Andrew L ^a,b   Patterson, Kathleen ^a   Gown, Allen M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

CD56; CD99; Immunohistochemistry; NB 84; Neuroblastoma

Indexed keywords

CD56 ANTIGEN; DESMIN; DESMIN ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 56; MONOCLONAL ANTIBODY CD 99; MONOCLONAL ANTIBODY NB 84; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN RETRIEVAL; ARTICLE; CHILD; CHILDHOOD CANCER; CHONDROSARCOMA; DIFFERENTIAL DIAGNOSIS; ESTHESIONEUROBLASTOMA; EWING SARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SMALL BLUE ROUND CELL TUMOR;

EID: 0031421014     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199712000-00006     Document Type: Article

References (46)

1. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18:486-94.
2. Miettinin M, Lehto VP, Bradley RA, Virtanen I. Alveolar rhabdomyosarcoma: demonstration of the muscle type of intermediate filament, desmin, as a diagnostic aid. Am J Pathol 1982;108:246-51.
3. Grantner SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol 1996;27:1273-6.
4. DeiTos AP, Wadden C, Calonje E, et al. Immunohistochemical demonstration of glycoprotein p30/32MIC2 (CD99) in synovial sarcoma: a potential cause of diagnostic confusion. Applied Immunohistochemistry 1995;3:168-73.
5. Parham DM, Dias P, Kelly DR, Rutledge JC, Houghton P. Desmin positivity in primitive neuroectodermal tumors of childhood. Am J Surg Pathol 1992;16:483.
6. Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kemshead JT, Sawada T. Alpha-smooth muscle actin and desmin positive human neuroblastoma cell lines. Proc Am Assoc Cancer Res 1990;31:21.
7. Folpe AL, Patterson K, Gown AM. The blastemal component of Wilms tumor expresses desmin but not other myogenic proteins. Mod Pathol 1997;10:895-900.
8. Giudici AM, Sher E, Pelagi M, Clementi F, Zanini A. Immunolocalization of secretogranin II, chromogranin A, and chromogranin B in differentiating human neuroblastoma cells. Eur J Cell Biol 1992;58:383-9.
9. Franquemont DW, Mills SE, Lack EE. Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma. Am J Clin Pathol 1994;102:163-70.
10. Nguyen AV, Argenyi ZB. Cutaneous neuroblastoma: peripheral neuroblastoma. Am J Dermatopathol 1993;15:7-14.
11. Wirnsberger GH, Becker H, Ziervogel K, Hofler H. Diagnostic immunohistochemistry of neuroblastic tumors. Am J Surg Pathol 1992;16:49-57.
12. Pagani A, Forni M, Tonini GP, Papotti M, Bussolati G. Expression of members of the chromogranin family in primary neuroblastomas. Diagn Mol Pathol 1992;1:16-24.
13. Frank DK, Ramswamy G, Tavin E, Moscatello AL. Poorly differentiated pediatric head and neck neuroblastoma: a diagnostic dilemma. Int J Pediatr Otorhinolaryngol 1995;33:103-11.
14. Shrestha P, Yang L, Liu B, et al. Neuroblastoma of parotid gland: report of a case and immunohistochemical characterization. Eur J Cancer B Oral Oncol 1994;30:356-61.
15. Pilkington GR, Pallesen G. Phenotypic characterization of non-hematopoietic small cell tumors of childhood with monoclonal antibodies to leukocytes, epithelial cells, and cytoskeletal proteins. Histopathology 1989;14:347-57.
16. Bigotti G, Coli A. Histopathologic and immunohistochemical features of neuroblastoma: a tool for evaluating prognosis. Tumori 1990;76:374-8.
17. Becker H, Wirnsberger G, Ziervogel K, Hofler H. Immunohistochemical markers in (ganglio) neuroblastomas. Acta Histochem Suppl 1990;38:107-14.
18. Carter RL, Al-Sams SZ, Corbett RP, Clinton S. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumors in children. Histopathology 1990;16:461-7.
19. Roth J, Zuber C, Wagner P, et al. Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci USA 1988;85:2999-3003.
20. Molenaar WM, de Leij L, Trojanowski JQ. Neuroectodermal tumors of the peripheral and central nervous system share neuroendocrine N-CAM-related antigens with small cell carcinomas. Acta Neuropathol (Berl) 1991;83:46-54.
21. Garin-Chesa P, Fellinger EJ, Huvos AG, et al. Immunohistochemical analysis of neural cell adhesion molecules: differential expression in small round cell tumors of childhood and adolescence. Am J Pathol 1991;139:275-86.
22. Nagai J, Kigasawa H, Tomioka K, Koga N, Nishihara H, Nagao T. Immunocytochemical detection of bone marrow-invasive neuroblastoma cells. Eur J Haematol 1994;53:74-7.
23. Miettinin M, Cupo W. Neural cell adhesion molecule distribution in soft tissue tumors. Hum Pathol 1993;24:62-6.
24. Mechtersheimer G, Staudter M, Moller P. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res 1991; 51:1300-7.
25. Thomas JO, Nijjar J, Turley H, Micklem K, Gatter KC. NB-84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material. J Pathol 1991;163:69-75.
26. Miettinen M, Chatten J, Pactau A, Stevenson A. Immunohistochemical differential diagnosis of small round cell tumors with monoclonal antibodies NB-84 and CD99 [abstract]. Mod Pathol 1996;9:151A.
27. Joshi VV, Silverman JF. Pathology of neuroblastic tumors. Semin Diagn Pathol 1994;11:107-17.
28. Shimada H, Chatten J, Newton WH, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
29. Daugard S, Kamby C, Sunde LM, Myrhe-Jensen O, Scjioedt T. Ewing's sarcoma: a retrospective study of histological and immunohistochemical factors and their relation to prognosis. Virchows Arch (A) 1989;414:243-51.
30. Tsokos M, Linnoila RI, Chandra RS, Triche TJ. Neuron specific enolase in diagnosis of neuroblastoma and other small, round cell tumors in children. Hum Pathol 1984;15:575-84.
31. Stevenson AJ, Chatten J, Bertoni F, Miettinen M. CD99 (p30/32 MIC2) neuroectodermal/Ewing's sarcoma associated antigen as immunohistochemical marker: review of more than 600 tumors and the literature experience. Applied Immunohistochemistry 1994; 2:231-10.
32. Ambras IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors: evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886-93.
33. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991;139:317-25.
34. Perlman EJ, Dickan PS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma: routine diagnostic utilization of MIC2 analysis. A Pediatric Oncology Group/children's Cancer Group Intergroup study. Hum Pathol 1994;25:304-7.
35. Ramani P, Rampling D, Link M. Immunocytochemical study of 12E7 in small round-cell tumors of childhood: an assessment of its sensitivity and specificity. Histopathology 1993;23:557-61.
36. Fellinger EJ, Garin-Chesa P, Glasser DB, Huvos AG, Rettig WJ. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone. Am J Surg Pathol 1992;16: 746-55.
37. Fellinger EJ, Garin-Chesa P, Su SL, DeAngelis P, Lane JM, Rettig WJ. Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen. Cancer Res 1991;51:336-40.
38. Perlman EJ, Lumadue JA, Hawkins AL, Cohen K, Colombani P, Griffin CA. Primary cutaneous neuroendocrine tumors: diagnostic use of cytogenetics and MIC2 analysis. Cancer Genet Cytogenet 1995;82:30-4.
39. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994;25:396-9.
40. Devaney K, Vinh TN, Sweet DE. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic consideration. Hum Pathol 1994;25:1211-25.
41. Nelson RS, Perlman EJ, Askin FB. Is esthesioneuroblastoma a peripheral neuroectodermal tumor? Hum Pathol 1995;26:639-41.
42. Altmannsberger M, Weber K, Droste R, Osborn M. Desmin is a specific marker of rhabdomyosarcomas of human and rat origin. Am J Pathol 1985;118:85-95.
43. Truong LD, Randaeng S, Cagle P, Ro JY, Hawkins H, Font RL. The diagnostic utility of desmin. Am J Clin Pathol 1990;93: 305-14.
44. Rangdaeng S, Truong LD. Comparative immunohistochemical staining for desmin and muscle-specific actin: a study of 576 cases. Am J Clin Pathol 1991;96:32-45.
45. Parham DM, Webber B, Holt H, Williams WK, Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms: results of an intergroup rhabdomyosarcoma study project. Cancer 1991;67:3072-80.
46. Swanson PE. HIERanarchy: The state of the art in immunohistochemistry. Am J Clin Path 1997;107:139-40.